CVS.F
CVS Health Corporation
FrankfurtEUREQUITY
Healthcare
DELAYED
Last price
79.38
▼ 0.54 (0.68%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
79.38
Prev close
79.92
Day high
79.38
Day low
79.38
Volume
22
Market cap
$101.52B
P/E (TTM)
24.50
52W range
59.57 – 96.66
Day trading desk
Gap from prior close
-0.68%
Prior close 79.92
VWAP
—
—
Relative volume
0.00×
Quiet session
Session range
—
79.38 – 79.38
Position in range
—
—
ATR (14D)
1.25
1.57% of price
Prior day high
79.92
PDH
Prior day low
79.92
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Avg 98
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-2.63%
-1.4%
1M
-15.26%
-18.5%
3M
+2.06%
-0.3%
6M
+24.52%
+12.7%
YTD
+16.68%
+4.8%
1Y
+30.58%
+10.5%
3Y
+29.03%
-45.8%
5Y
+10.37%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on CVS.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
805.75K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| May 21, 26 | ROBBINS LARRY Director |
SELL | 3.37M | $317.47M | Indirect |
| May 14, 26 | BALSER JEFFREY R M.D., PH.D. Director |
STOCK | 2.06K | $199.94K | Direct |
| May 14, 26 | NORWALK LESLIE V Director |
STOCK | 1.45K | $140.58K | Direct |
| May 14, 26 | KIRBY JOHN SCOTT Director |
STOCK | 1.45K | $140.58K | Direct |
| May 14, 26 | SANSONE GUY P Director |
STOCK | 1.45K | $140.58K | Direct |
| May 14, 26 | BROWN C DAVID II Director |
STOCK | 1.54K | $150.00K | Direct |
| May 14, 26 | AGUIRRE FERNANDO Director |
STOCK | 1.56K | $151.84K | Direct |
| May 8, 26 | MANDADI TILAK Officer |
SELL | 69.55K | $6.23M | Direct |
| Mar 31, 26 | MANDADI TILAK Officer |
STOCK | 22.28K | $1.60M | Direct |
| Mar 31, 26 | SHAH PREM S Officer |
STOCK | 25.06K | $1.80M | Direct |
| Mar 31, 26 | CLARK JAMES DAVID Officer |
STOCK | 11.14K | $799.93K | Direct |
| Mar 31, 26 | NEWMAN BRIAN Chief Financial Officer |
STOCK | 19.49K | $1.40M | Direct |
| Mar 31, 26 | COMPTON-PHILLIPS AMY Officer |
STOCK | 5.57K | $399.97K | Direct |
| Mar 31, 26 | KHICHI SAMRAT S General Counsel |
STOCK | 12.53K | $899.98K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BROWN C DAVID II |
Director | 129.32K | Stock Award(Grant) |
CAPOZZI HEIDI B |
Officer | 97.47K | Stock Award(Grant) |
COMPTON-PHILLIPS AMY |
Officer | 58.66K | Stock Award(Grant) |
COWHEY THOMAS F. |
Chief Financial Officer | 91.30K | Stock Award(Grant) |
FARAH ROGER N |
Director | 54.25K | Stock Award(Grant) |
JOYNER JOHN DAVID |
Chief Executive Officer | 231.21K | Stock Award(Grant) |
KHICHI SAMRAT S |
General Counsel | 71.56K | Stock Award(Grant) |
MILLON JEAN PIERRE |
Director | 112.22K | Stock Award(Grant) |
ROBBINS LARRY |
Director | — | Sale |
SHAH PREM S |
Officer | 127.21K | Stock Award(Grant) |
Fundamentals
Market cap$101.52B
Enterprise value$164.76B
Revenue (TTM)$412.64B
Gross profit$56.31B
EBITDA$16.68B
Net income$4.89B
EPS (TTM)$3.24
Free cash flow$8.08B
Total cash$13.96B
Total debt$76.31B
Book value / share$53.36
Shares outstanding1.28B
Float1.28B
Short % of float—
Dividend yield2.88%
Beta (5Y)0.60
Valuation & profitability ratios
Trailing P/E24.50
Forward P/E—
PEG ratio0.26
Price / sales—
Price / book1.49
EV / revenue0.40
EV / EBITDA9.88
Gross margin13.65%
Operating margin3.86%
Profit margin1.18%
Return on equity6.21%
Return on assets2.97%
Debt / equity95.50
Current ratio0.87
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $402.07B | $372.81B | $357.78B | $322.47B | +7.8% |
| Operating revenue | $402.07B | $372.81B | $357.78B | $322.47B | +7.8% |
| Cost of revenue | $346.70B | $321.41B | $303.35B | $267.96B | +7.9% |
| Gross profit | $55.36B | $51.40B | $54.43B | $54.50B | +7.7% |
| Total operating expense | $44.98B | $41.71B | $39.83B | $38.21B | +7.8% |
| Operating income | $10.38B | $9.70B | $14.60B | $16.29B | +7.1% |
| Net interest income | -$3.12B | -$2.96B | -$2.66B | -$2.29B | -5.4% |
| Pre-tax income | $2.14B | $6.15B | $11.17B | $5.84B | -65.3% |
| Tax provision | $408.00M | $1.56B | $2.81B | $1.51B | -73.9% |
| Net income | $1.77B | $4.61B | $8.34B | $4.31B | -61.7% |
| Net income to common | $1.77B | $4.61B | $8.34B | $4.31B | -61.7% |
| Basic EPS | 1.40 | 3.67 | 6.49 | 3.29 | -61.9% |
| Diluted EPS | 1.39 | 3.66 | 6.47 | 3.26 | -62.0% |
| EBIT | $5.25B | $9.11B | $13.83B | $8.12B | -42.3% |
| EBITDA | $9.86B | $13.70B | $18.20B | $12.35B | -28.0% |
| Basic shares | 1.27B | 1.26B | 1.28B | 1.31B | +0.6% |
| Diluted shares | 1.27B | 1.26B | 1.29B | 1.32B | +0.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $8.45B | $8.59B | $8.20B | $12.95B | -1.5% |
| Cash & short-term investments | $10.60B | $10.99B | $11.46B | $15.72B | -3.6% |
| Accounts receivable | $16.32B | $14.61B | $15.62B | $11.66B | +11.7% |
| Inventory | $19.25B | $18.11B | $18.02B | $19.09B | +6.3% |
| Total current assets | $74.71B | $68.64B | $67.86B | $65.63B | +8.8% |
| Property, plant & equipment | $28.06B | $28.94B | $30.43B | $30.75B | -3.0% |
| Goodwill & intangibles | $110.99B | $118.59B | $120.51B | $102.95B | -6.4% |
| Total assets | $253.54B | $253.22B | $249.73B | $228.28B | +0.1% |
| Total current liabilities | $88.69B | $84.61B | $79.19B | $69.42B | +4.8% |
| Current debt | $4.07B | $5.74B | $2.97B | $1.78B | -29.2% |
| Long-term debt | $60.50B | $60.53B | $58.64B | $50.48B | -0.0% |
| Total debt | $79.95B | $82.92B | $79.39B | $70.73B | -3.6% |
| Total liabilities | $178.16B | $177.49B | $173.09B | $156.51B | +0.4% |
| Retained earnings | $61.20B | $62.84B | $61.60B | $56.40B | -2.6% |
| Shareholder equity | $75.21B | $75.56B | $76.46B | $71.47B | -0.5% |
| Working capital | -$13.98B | -$15.96B | -$11.33B | -$3.79B | +12.4% |
| Net tangible assets | -$35.77B | -$43.03B | -$44.05B | -$31.48B | +16.9% |
| Shares issued | 1.79B | 1.78B | 1.77B | 1.76B | +0.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $1.73B | $4.59B | $8.37B | $4.33B | -62.3% |
| Depreciation & amortisation | $4.61B | $4.60B | $4.37B | $4.22B | +0.2% |
| Stock-based compensation | $535.00M | $540.00M | $588.00M | $447.00M | -0.9% |
| Change in working capital | -$1.47B | $109.00M | $15.00M | $6.82B | -1,452.3% |
| Operating cash flow | $10.64B | $9.11B | $13.43B | $16.18B | +16.8% |
| Capital expenditure | -$2.83B | -$2.78B | -$3.03B | -$2.73B | -1.8% |
| Investing cash flow | -$5.87B | -$7.61B | -$20.89B | -$5.05B | +22.9% |
| Share buybacks | $0 | -$3.02B | -$2.01B | -$3.50B | +100.0% |
| Dividends paid | -$3.40B | -$3.37B | -$3.13B | -$2.91B | -0.7% |
| Financing cash flow | -$4.94B | -$1.14B | $2.68B | -$10.52B | -335.2% |
| Free cash flow | $7.81B | $6.33B | $10.39B | $13.45B | +23.4% |
| End cash position | $8.71B | $8.88B | $8.53B | $13.30B | -1.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $106.10B | $100.43B | $105.69B | $102.87B | $98.92B | — | +5.6% |
| Operating revenue | $106.10B | $100.43B | $105.69B | $102.87B | $98.92B | — | +5.6% |
| Cost of revenue | $90.35B | $84.80B | $92.13B | $89.06B | $85.32B | — | +6.5% |
| Gross profit | $15.75B | $15.62B | $13.57B | $13.81B | $13.59B | — | +0.8% |
| Total operating expense | $11.05B | $10.94B | $11.46B | $11.29B | $11.21B | — | +0.9% |
| Operating income | $4.70B | $4.68B | $2.11B | $2.52B | $2.38B | — | +0.5% |
| Net interest income | -$757.00M | -$774.00M | -$787.00M | -$784.00M | -$763.00M | — | +2.2% |
| Pre-tax income | $3.98B | $3.94B | $1.35B | -$3.48B | $1.65B | — | +1.0% |
| Tax provision | $982.00M | $981.00M | -$1.57B | $508.00M | $634.00M | — | +0.1% |
| Net income | $2.98B | $2.94B | $2.94B | -$3.98B | $1.02B | — | +1.2% |
| Net income to common | $2.98B | $2.94B | $2.94B | -$3.98B | $1.02B | — | +1.2% |
| Basic EPS | 2.33 | 2.31 | 2.32 | — | 0.81 | 1.41 | +0.9% |
| Diluted EPS | 2.31 | 2.30 | 2.30 | — | 0.80 | 1.41 | +0.4% |
| EBIT | $4.73B | $4.71B | $2.14B | -$2.70B | $2.41B | — | +0.5% |
| EBITDA | $5.86B | $5.83B | $3.29B | -$1.56B | $3.58B | — | +0.6% |
| Basic shares | 1.28B | 1.27B | 1.27B | — | 1.27B | 1.26B | +0.5% |
| Diluted shares | 1.29B | 1.28B | 1.28B | — | 1.27B | 1.26B | +0.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $11.33B | $9.54B | $8.45B | $9.10B | $11.79B | +18.7% |
| Cash & short-term investments | $13.96B | $11.80B | $10.60B | $11.23B | $14.17B | +18.3% |
| Accounts receivable | $19.38B | $20.14B | $16.32B | $16.10B | $16.35B | -3.8% |
| Inventory | $17.62B | $17.77B | $19.25B | $18.96B | $17.45B | -0.8% |
| Total current assets | $75.35B | $74.82B | $74.71B | $77.11B | $75.65B | +0.7% |
| Property, plant & equipment | $27.62B | $27.78B | $28.06B | $28.11B | $28.34B | -0.6% |
| Goodwill & intangibles | $110.12B | $110.55B | $110.99B | $111.46B | $117.43B | -0.4% |
| Total assets | $253.77B | $252.97B | $253.54B | $255.33B | $258.34B | +0.3% |
| Total current liabilities | $87.04B | $86.41B | $88.69B | $92.69B | $94.16B | +0.7% |
| Current debt | $1.96B | $2.58B | $4.07B | $5.33B | $9.20B | -24.1% |
| Long-term debt | $59.45B | $60.53B | $60.50B | $60.51B | $57.29B | -1.8% |
| Total debt | $76.31B | $78.34B | $79.95B | $81.75B | $82.72B | -2.6% |
| Total liabilities | $173.87B | $175.34B | $178.16B | $182.22B | $180.79B | -0.8% |
| Retained earnings | $65.40B | $63.28B | $61.20B | $59.11B | $63.94B | +3.3% |
| Shareholder equity | $79.70B | $77.46B | $75.21B | $72.93B | $77.38B | +2.9% |
| Working capital | -$11.70B | -$11.59B | -$13.98B | -$15.59B | -$18.51B | -0.9% |
| Net tangible assets | -$30.42B | -$33.09B | -$35.77B | -$38.53B | -$40.05B | +8.1% |
| Shares issued | 1.28B | 1.79B | 1.79B | 1.79B | 1.78B | -28.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $3.00B | $2.96B | $2.92B | -$3.99B | $1.01B | — | +1.3% |
| Depreciation & amortisation | $1.13B | $1.11B | $1.15B | $1.13B | $1.17B | — | +1.0% |
| Stock-based compensation | $176.00M | $266.00M | $135.00M | $138.00M | $136.00M | — | -33.8% |
| Change in working capital | $2.20B | $2.00M | -$1.02B | -$1.57B | -$309.00M | — | +109,800.0% |
| Operating cash flow | $6.34B | $4.25B | $3.39B | $796.00M | $1.90B | — | +49.3% |
| Capital expenditure | -$691.00M | -$849.00M | -$784.00M | -$698.00M | -$607.00M | — | +18.6% |
| Investing cash flow | -$1.88B | -$874.00M | -$2.00B | -$2.09B | -$1.02B | — | -115.6% |
| Share buybacks | — | — | $0 | $0 | $0 | $0 | — |
| Dividends paid | -$878.00M | -$847.00M | -$845.00M | -$846.00M | -$866.00M | — | -3.7% |
| Financing cash flow | -$2.69B | -$2.32B | -$2.03B | -$1.38B | $806.00M | — | -16.2% |
| Free cash flow | $5.65B | $3.40B | $2.61B | $98.00M | $1.29B | — | +66.3% |
| End cash position | $11.54B | $9.77B | $8.71B | $9.35B | $12.03B | — | +18.1% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $104.55B | +1.6% |
| Next quarter | — | — | $106.88B | +1.1% |
| Current year | — | — | $417.46B | +3.8% |
| Next year | — | — | $429.05B | +2.8% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.06%
Held by institutions90.86%
Institutions holding2.65K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
80.99
-1.99% from price
SMA 20
85.22
-6.86% from price
SMA 50
88.80
-10.61% from price
SMA 100
81.83
-3.00% from price
SMA 200
74.04
+7.21% from price
EMA 12
82.13
-3.35% from price
EMA 26
85.00
-6.61% from price
EMA 50
85.57
-7.24% from price
RSI (14)
28.3
Oversold
MACD (12,26,9)
-2.87
Hist -0.53
ATR (14)
1.25
1.57% of price
Realised vol 30D
27.7%
Annualised
Bollinger upper
95.81
20, 2σ
Bollinger lower
74.64
20, 2σ
50 / 200 cross
Golden
88.80 vs 74.04
Trend bias
Above 200
+7.21%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.11
Less volatile than market
Correlation to SPY
0.04
Largely independent
Realised vol 30D
27.7%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-17.3%
Peak to trough
Max drawdown 5Y
-59.7%
Peak to trough
ATR 14
1.25
1.57% of price
Beta (reported)
0.60
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 19, 26 | Argus Research | MAINTAINED | Buy | Buy |
| Aug 12, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Aug 6, 26 | UBS | MAINTAINED | Buy | Buy |
| Aug 6, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Aug 6, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Jul 25, 26 | UBS | MAINTAINED | Buy | Buy |
| Jul 14, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Jul 13, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Jul 9, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jul 7, 26 | Cantor Fitzgerald | MAINTAINED | Overweight | Overweight |
| Jun 23, 26 | B of A Securities | MAINTAINED | Buy | Buy |
| Jun 8, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
Dividends & splits
Forward rate$2.30 / yr
Forward yield2.88%
5-year avg yield3.25%
Payout ratio70.18%
Ex-dividend dateJul 23, 2026
Next pay date—
Last split—
Split date—
Headlines
IHCL to merge Oriental Hotels under proposed share-swap deal
Hotel Management Network · 4m ago
Houlihan Lokey (HLI): Buy, Sell, or Hold Post Q2 Earnings?
StockStory · 5m ago
LIVE: US unveils new sanctions on Iran
Yahoo Finance Video · 6m ago
CPK chooses T-ROC Global to deploy automated food kiosks
Verdict Food Service · 8m ago
Dunkin’ and BARK Unleash First-Ever Doggie Drive-Thru
QSR · 9m ago
XPENG Reports Q2 2026 Results: Gross Margin Reaches 20.7%, Overseas Market Drives 25% of H1 Revenue
PR Newswire · 10m ago
Cut Flowers Market Size to Reach $52.78 Billion by 2031 as Online Ordering and Cold-Chain Innovation Reshape Global Trade, Reports Mordor Intelligence
PR Newswire · 11m ago
Visy launches automated labelling system for fresh produce packs
Packaging Gateway · 11m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.